Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Endorepellin is the 85-kDa C-terminal domain V of HSPG2 (per...

Class:IdSummation:3814824
_displayNameEndorepellin is the 85-kDa C-terminal domain V of HSPG2 (per...
_timestamp2013-07-09 09:44:59
created[InstanceEdit:3814823] Jupe, S, 2013-07-08
literatureReference[LiteratureReference:3827969] Domain structure and organisation in extracellular matrix proteins
[LiteratureReference:2396059] Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan
[LiteratureReference:2396054] Endorepellin causes endothelial cell disassembly of actin cytoskeleton and focal adhesions through alpha2beta1 integrin
[LiteratureReference:3828012] BMP-1/Tolloid-like metalloproteases process endorepellin, the angiostatic C-terminal fragment of perlecan
[LiteratureReference:3828007] Caspase-3 activation triggers extracellular cathepsin L release and endorepellin proteolysis
modified[InstanceEdit:3814826] Jupe, S, 2013-07-08
[InstanceEdit:3827985] Jupe, S, 2013-07-09
textEndorepellin is the 85-kDa C-terminal domain V of HSPG2 (perlecan). It consists of a series of laminin-like globular (LG) domains interconnected by short epidermal growth factor-like repeats (Hohenester & Engel 2002). Endorepellin has angiostatic activity (Mongiat et al. 2003) which is primarily localised in the LG3 domain (Bix et al. 2004). Bone morphogenetic protein 1 (BMP1), its isoform mammalian Tolloid (mTLD), mammalian Tolloid-like-1 and -2 (TLL1, TLL2) (Gonzalez et al. 2005) and cathepsin-L1 (Cailhier et al. 2008) can liberate LG3 by cleaving endorepellin between Asn4196 and Asp4197.
(summation)[Reaction:3814820] HSPG2 (perlecan) is cleaved by BMP1, TLL1, TLL2, Cathepsin L1 [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by Endorepellin is the 85-kDa C-terminal domain V of HSPG2 (per... (3814824)